Cargando…
Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Diabetes Association
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369206/ https://www.ncbi.nlm.nih.gov/pubmed/34352990 http://dx.doi.org/10.4093/dmj.2021.0081 |
| _version_ | 1783739243870289920 |
|---|---|
| author | Schernthaner, Guntram |
| author_facet | Schernthaner, Guntram |
| author_sort | Schernthaner, Guntram |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8369206 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Diabetes Association |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-83692062021-08-26 Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) Schernthaner, Guntram Diabetes Metab J Letter Korean Diabetes Association 2021-07 2021-07-30 /pmc/articles/PMC8369206/ /pubmed/34352990 http://dx.doi.org/10.4093/dmj.2021.0081 Text en Copyright © 2021 Korean Diabetes Association https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Schernthaner, Guntram Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) |
| title | Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) |
| title_full | Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) |
| title_fullStr | Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) |
| title_full_unstemmed | Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) |
| title_short | Effects of a DPP-4 Inhibitor and RAS Blockade on Clinical Outcomes of Patients with Diabetes and COVID-19 (Diabetes Metab J 2021;45:251-9) |
| title_sort | effects of a dpp-4 inhibitor and ras blockade on clinical outcomes of patients with diabetes and covid-19 (diabetes metab j 2021;45:251-9) |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8369206/ https://www.ncbi.nlm.nih.gov/pubmed/34352990 http://dx.doi.org/10.4093/dmj.2021.0081 |
| work_keys_str_mv | AT schernthanerguntram effectsofadpp4inhibitorandrasblockadeonclinicaloutcomesofpatientswithdiabetesandcovid19diabetesmetabj2021452519 |